Biologically equivalent substitutive technology: what is needed to manufacture pluripotent stem cells for next-generation platforms for discovery and therapy

Paul A. De Sousa*

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Pages (from-to)519-521
Number of pages3
JournalRegenerative medicine
Issue number5
Publication statusPublished - Sept 2013

Keywords / Materials (for Non-textual outputs)

  • bioprocessing
  • cell culture
  • drug delivery
  • polymer substrate
  • small molecule
  • FATE

Cite this